Skip to search formSkip to main contentSkip to account menu

Moricizine

Known as: Moracizinum, Moracizin, Moricizine [Chemical/Ingredient] 
An antiarrhythmia agent used primarily for ventricular rhythm disturbances.
National Institutes of Health

Related topics

Related topics

20 relations

Broader (2)

Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers
Bundle-Branch BlockDrug AllergyIn BloodMoricizine hydrochloride

Narrower (5)

EN-313Ethmozinediethylamino-ethmozinemethacizine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2003
Review
2003
Outpatient prescribing of antiarrhythmic drugs from 1995 to 2000.
Review
1995
Review
1995
Amiodarone: Reevaluation of an Old Drug
In most patients, therapy for arrhythmia involves the administration of antiarrhythmic agents, but recent developments have… 
1995
1995
Time to arrhythmic, ischemic, and heart failure events: exploratory analyses to elucidate mechanisms of adverse drug effects in the Cardiac Arrhythmia Suppression Trial.
Highly Cited
1994
Highly Cited
1994
Interaction of Baseline Characteristics With The Hazard of Encainide, Flecainide, and Moricizine Therapy in Patients With Myocardial Infarction: A Possible Explanation for Increased Mortality in the…
BackgroundThe Cardiac Arrhythmia Suppression Trial (CAST) was designed to test the hypothesis that suppression of ventricular… 
Highly Cited
1993
Highly Cited
1993
Complexation of moricizine with nicotinamide and evaluation of the complexation constants by various methods.
The solubility of the antiarrhythmic drug moricizine at physiologic pH is very low. Precipitation after rapid intravenous… 
Review
1992
Review
1992
Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.
Amiodarone, originally developed over 20 years ago, is a potent antiarrhythmic drug with the actions of all antiarrhythmic drug… 
1992
1992
Effects of Advancing Age on the Efficacy and Side Effects of Antiarrhythmic Drugs in Post‐Myocardial Infarction Patients with Ventricular Arrhythmias
To determine the effect of age on the response to anti‐arrhythmic drugs. 
Highly Cited
1991
Highly Cited
1991
Increased risk of death and cardiac arrest from encainide and flecainide in patients after non-Q-wave acute myocardial infarction in the Cardiac Arrhythmia Suppression Trial. CAST Investigators.
Highly Cited
1991
Highly Cited
1991
Proarrhythmic response to sodium channel blockade. Theoretical model and numerical experiments.
BACKGROUND The use of flecainide and encainide was terminated in the Cardiac Arrhythmia Suppression Trial because of an excess of… 
Highly Cited
1988
Highly Cited
1988
Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)